#  @Angelnvestments Angel Investments Angel Investments posts on X about $srpt, $tsla, $clov, tsla the most. They currently have [---] followers and [--] posts still getting attention that total [--] engagements in the last [--] hours. ### Engagements: [--] [#](/creator/twitter::1375067821412089858/interactions)  - [--] Week [-----] +8,338% - [--] Month [-----] +5.40% - [--] Months [------] +30,770% - [--] Year [------] +2,383% ### Mentions: [--] [#](/creator/twitter::1375067821412089858/posts_active)  - [--] Week [--] +100% - [--] Month [--] +75% - [--] Months [--] +3,200% - [--] Year [--] +183% ### Followers: [---] [#](/creator/twitter::1375067821412089858/followers)  - [--] Month [---] +1.80% - [--] Months [---] +34% - [--] Year [---] +39% ### CreatorRank: [---------] [#](/creator/twitter::1375067821412089858/influencer_rank)  ### Social Influence **Social category influence** [stocks](/list/stocks) 79.59% [technology brands](/list/technology-brands) 12.24% [finance](/list/finance) 10.2% [cryptocurrencies](/list/cryptocurrencies) 8.16% [automotive brands](/list/automotive-brands) 6.12% [countries](/list/countries) 4.08% [us election](/list/us-election) 2.04% **Social topic influence** [$srpt](/topic/$srpt) 53.06%, [$tsla](/topic/$tsla) 10.2%, [$clov](/topic/$clov) 10.2%, [tsla](/topic/tsla) 8.16%, [bitcoin](/topic/bitcoin) 6.12%, [strong](/topic/strong) 4.08%, [tesla](/topic/tesla) 4.08%, [$amzn](/topic/$amzn) 4.08%, [$crwd](/topic/$crwd) 4.08%, [ceo](/topic/ceo) 4.08% **Top accounts mentioned or mentioned by** [@usfda](/creator/undefined) [@stockmktnewz](/creator/undefined) [@sarepta](/creator/undefined) [@adamfeuerstein](/creator/undefined) [@jimcramers](/creator/undefined) [@jimcramer](/creator/undefined) [@wgaeast](/creator/undefined) [@theafm](/creator/undefined) [@directorsguild](/creator/undefined) [@iatse](/creator/undefined) [@teamsters](/creator/undefined) [@teamsters399](/creator/undefined) [@sagaftra](/creator/undefined) [@optionsheisman](/creator/undefined) [@emerginvestor](/creator/undefined) [@bironclark](/creator/undefined) [@drmakaryfda](/creator/undefined) [@susiewiles](/creator/undefined) [@douglasingram](/creator/undefined) [@robertkennedyjr](/creator/undefined) **Top assets mentioned** [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Tesla, Inc. (TSLA)](/topic/$tsla) [Bitcoin (BTC)](/topic/bitcoin) [Amazon.com, Inc. (AMZN)](/topic/$amzn) [Crowdstrike Holdings Inc (CRWD)](/topic/$crwd) [Freeport-McMoRan Inc (FCX)](/topic/$fcx) [Bill.com Holdings, Inc. (BILL)](/topic/$bill) [Riskified Ltd. (RSKD)](/topic/$rskd) [MARA Holdings, Inc. (MARA)](/topic/$mara) [CATHEDRA BITCOIN SUB VTG (CBTTF)](/topic/$cbttf) [Hut [--] Mining Corp. (HUT)](/topic/$hut) [Apple, Inc. (AAPL)](/topic/$aapl) [NVIDIA Corp. (NVDA)](/topic/$nvda) [Gains (GAINS)](/topic/gains) [Stronghold Digital Mining, Inc. (SDIG)](/topic/$sdig) [Bitfarms Ltd. (BITF)](/topic/bitfarms) [Lumerin (LMR)](/topic/$lmr) ### Top Social Posts Top posts by engagements in the last [--] hours "$SRPT mixing unrelated bad news into this and Adam can spin any conclusion. If the data were weak it wouldnt need population mixing to attack it. Ambulatory outcomes should be judged on ambulatory data. $SRPT 📷 So misleading by @adamfeuerstein: In this morning's press release this is all that $SRPT discloses about Elevidys safety one year after liver toxicity liver-injury related hospitalizations and deaths due to acute liver failure nearly ended the gene therapy. $SRPT 📷 So misleading by @adamfeuerstein: In this morning's press release this is all that $SRPT discloses about Elevidys safety" [X Link](https://x.com/Angelnvestments/status/2016187474603552971) 2026-01-27T16:32Z [---] followers, [---] engagements "The drug is ready to be tested in people. For brain drugs getting to this point is already a big hurdle. This is where $SRPT starts answering the most important question: can the drug reach the right place and be safe And for Huntingtons that alone makes it worth watching. $SRPT Announces Approval of Clinical Trial Application for SRP-1005 Its Investigational Treatment for Huntingtons Disease The first-in-human clinical study of SRP-1005 known as INSIGHTT is expected to begin in Q2. $SRPT Announces Approval of Clinical Trial Application for SRP-1005 Its Investigational Treatment for" [X Link](https://x.com/Angelnvestments/status/2020453776151179574) 2026-02-08T11:04Z [---] followers, [---] engagements "$FCX has been holding its gains well after a strong run. Pullbacks look more like digestion than distribution which usually argues for continuation rather than a top" [X Link](https://x.com/Angelnvestments/status/2021453803896381685) 2026-02-11T05:18Z [---] followers, [--] engagements "What stands out here is platform optionality. CNS delivery has been the bottleneck for RNA therapies in neurodegeneration. Phase [--] is about proving the platform belongs in the brain. Safety and delivery come first everything else builds from there. This is a solid start. $SRPT 📢 : New Zealand Approves $SRPT Sareptas First-in-Human Trial for Huntingtons Drug 👉 : ➤ New Zealand regulator approves Sareptas - clinical trial application. ➤ Phase study to begin in 📢 : New Zealand Approves $SRPT Sareptas First-in-Human Trial for Huntingtons Drug 👉 : ➤ New Zealand regulator approves Sareptas -" [X Link](https://x.com/Angelnvestments/status/2021658348526145859) 2026-02-11T18:51Z [---] followers, [---] engagements "Top ETFs: $DWCR $QQQ" [X Link](https://x.com/Angelnvestments/status/1428336000854642689) 2021-08-19T12:40Z [--] followers, [--] engagements "Top Stock Gainers: $BILL $NEGG $CIIHF $ADGI $RSKD #stockstowatch #StockMarket" [X Link](https://x.com/Angelnvestments/status/1432053630086094855) 2021-08-29T18:52Z [--] followers, [--] engagements "Cathedral Bitcoin $CBIT.V $CBTTF is sneaking above the [--] and [---] dma coiling on the launch pad 🚀📈 Crypto stocks like $HUT $MARA $INTV starting to rev up with major volume. Volume often precedes price. Exciting times in the world of #Bitcoin and #cryptocurrency #CryptoStocks Cathedral Bitcoin $CBIT.V $CBTTF Price sneaking above [--] and [---] dma. Coiling on launch pad. Crypto stocks starting to rev. Major volume yesterday. Volume tends to precede price. $HUT $MARA $BTCUSD $INTV https://t.co/lcEaDWwFIW Cathedral Bitcoin $CBIT.V $CBTTF Price sneaking above [--] and [---] dma. Coiling on launch pad." [X Link](https://x.com/Angelnvestments/status/1646664563654537216) 2023-04-14T00:00Z [--] followers, [---] engagements "NEWS: @jimcramer's Lightning Round: Trane Technologies is a buy.🧐🙌 Its that time again #MadMoney host @jimcramer rings the lightning round bell which means hes giving his answers to callers stock questions at rapid speed. #Bitcoin #stockmarket $BTCL" [X Link](https://x.com/Angelnvestments/status/1816087372121137443) 2024-07-24T12:25Z [--] followers, [--] engagements "@WGAEast @The_AFM @directorsguild @IATSE @Teamsters @Teamsters_399 @sagaftra Unions and video game studios don't have the best relationship. Not many games will use unionized labor when equally talented VA are available or now AI can do it for much less. Union workers might lose their job opportunities" [X Link](https://x.com/Angelnvestments/status/1818613933877383425) 2024-07-31T11:45Z [--] followers, [--] engagements "Analyst Predicts 'Explosive' $BTC Growth to $150K as Four-Year Cycle Advances. Check it out here👇 https://finance.yahoo.com/news/analyst-predicts-explosive-bitcoin-growth-085839736.html https://finance.yahoo.com/news/analyst-predicts-explosive-bitcoin-growth-085839736.html" [X Link](https://x.com/Angelnvestments/status/1843968525746184329) 2024-10-09T10:55Z [--] followers, [--] engagements "MacBook Pro Release Date Latest: Apples Ambitious Plans $AAPL #apple https://www.forbes.com/sites/ewanspence/2024/10/27/macbook-pro-release-date-latest-apples-ambitious-plans/ https://www.forbes.com/sites/ewanspence/2024/10/27/macbook-pro-release-date-latest-apples-ambitious-plans/" [X Link](https://x.com/Angelnvestments/status/1850782826527949135) 2024-10-28T06:13Z [--] followers, [--] engagements "@StockMKTNewz technology is gold: 1) $TSLA 2) $NNDM 3) $CLOV" [X Link](https://x.com/Angelnvestments/status/1850784576982974701) 2024-10-28T06:20Z [--] followers, [---] engagements "Tesla shares lost nearly 7% over the last two trading sessions closing Friday at $431.66. $TSLA #DonaldTrump https://www.investopedia.com/watch-these-tesla-price-levels-as-stock-hits-brakes-ahead-of-q4-deliveries-report-8767370 https://www.investopedia.com/watch-these-tesla-price-levels-as-stock-hits-brakes-ahead-of-q4-deliveries-report-8767370" [X Link](https://x.com/Angelnvestments/status/1873670590386847800) 2024-12-30T10:00Z [--] followers, [--] engagements "Is Tesla Stock a Buy in [----] $TSLA #StocksToBuy https://www.fool.com/investing/2024/12/31/is-tesla-stock-a-buy-in-2025/ https://www.fool.com/investing/2024/12/31/is-tesla-stock-a-buy-in-2025/" [X Link](https://x.com/Angelnvestments/status/1874869377402917014) 2025-01-02T17:24Z [--] followers, [--] engagements "@StockMKTNewz go buy $TSLA" [X Link](https://x.com/Angelnvestments/status/1876566316448194825) 2025-01-07T09:47Z [--] followers, [---] engagements "@OptionsHeisman @StockMKTNewz do you think companies like $AAPL and $MSFT can re-enter this level of innovation or have $NVDA and $TSLA permanently shifted the balance of power" [X Link](https://x.com/Angelnvestments/status/1876568283840913476) 2025-01-07T09:55Z [--] followers, [---] engagements "reclaimed its [------] buy point during recent gains $AMZN https://www.investors.com/research/magnificent-seven-stocks-january-2025/ http://Amazon.com https://www.investors.com/research/magnificent-seven-stocks-january-2025/ http://Amazon.com" [X Link](https://x.com/Angelnvestments/status/1879211716573319626) 2025-01-14T16:59Z [--] followers, [--] engagements "@EmergInvestor Hard to bet against $AMZN. AWS alone makes them a contender.and any improvements in consumer confidence would push them further ahead" [X Link](https://x.com/Angelnvestments/status/1881749293721387305) 2025-01-21T17:02Z [--] followers, [--] engagements "@BironClark Long term plays take long term energy. adding slowly keeping an eye on $SRPT too" [X Link](https://x.com/Angelnvestments/status/1941182637349142820) 2025-07-04T17:09Z [--] followers, [--] engagements "$SRPT doing $1.4B without non-ambulatory. Markets only pricing in risk. Not potential. If the sirolimus combo works in non ambulatory patientsTheres no ceiling on Elevidys anymore. Half the DMD market unlock Dr. Barry explains that liver toxicity in non amb patients can be addressed with sirolimus. $srpt is using far less than transplant level dosing just enough to calm the immune system shield the liver and avoid the collateral damage that comes with heavier dosing- safer. Dr. Barry explains that liver toxicity in non amb patients can be addressed with sirolimus. $srpt is using far less than" [X Link](https://x.com/Angelnvestments/status/1957898203111780543) 2025-08-19T20:11Z [--] followers, [----] engagements "$SRPT a diagnosis of Duchenne is almost a predetermined fate. Median life expectancy for Duchenne is just [--] years. So if a therapy gives even 3-5 more years of walking breathing living then its everything. And thats exactly what makes Elevidys so important. $SRPT 74% dead before [--] in DMD. If you call that safer than Elevidys youre gaslighting reality. Safety isnt dying on schedule $SRPT 74% dead before [--] in DMD. If you call that safer than Elevidys youre gaslighting reality. Safety isnt dying on schedule" [X Link](https://x.com/Angelnvestments/status/1960043751189238111) 2025-08-25T18:17Z [--] followers, [----] engagements "$SRPT Mr Adam says that like science isnt allowed to evolve. over a thousand kids got a shot at walking longer breathing better and zero death. If your biggest concern is the name of the endpoint not the outcome maybe youve forgotten who the real patient is Adam. Idk. Lot of criticism of $SRPT is fair. But hard to really say that a drug which is in such robust demand from the physician community is all smoke and mirrors. Its certainly not a perfect drug. But its also pretty clearly not inert from an efficacy perspective. Idk. Lot of criticism of $SRPT is fair. But hard to really say that a" [X Link](https://x.com/Angelnvestments/status/1960045791663509812) 2025-08-25T18:25Z [--] followers, [----] engagements "$SRPT Accelerated Approval was created for therapies that show surrogate benefit in serious conditions with no cures. Elevidys was the exact use case Congress envisioned. Anyone calling it controversial just simply doesnt understand the law" [X Link](https://x.com/Angelnvestments/status/1960389663241171172) 2025-08-26T17:11Z [--] followers, [---] engagements "$crwd eyes on [------] as the real trigger $CRWD beauty beauty beauty. Hope everyone caught this. https://t.co/vBrk4CPF7j $CRWD beauty beauty beauty. Hope everyone caught this. https://t.co/vBrk4CPF7j" [X Link](https://x.com/Angelnvestments/status/1961478418320568602) 2025-08-29T17:17Z [--] followers, [---] engagements "$CLOV New corp filings. New hires. New customers" [X Link](https://x.com/Angelnvestments/status/1961479604712943644) 2025-08-29T17:22Z [--] followers, [---] engagements "$SRPT We all know how quickly health can fade. Elevidys had offered a chance people should have the right to take it before the moment slips away. Childhood is short fragile and precious. No family should watch those steps disappear while answers sit waiting" [X Link](https://x.com/Angelnvestments/status/1962572286109561106) 2025-09-01T17:44Z [--] followers, [----] engagements "Every day we wait more families live this nightmare. Regulators and insurers please dont make parents choose which child survives $SRPT @DrMakaryFDA @US_FDA @SusieWiles @Sarepta @douglas_ingram $SRPT @RobertKennedyJr Please help these folks out of this unbelievably horrible situation @ArkBlueCross cannot do this to this family They cannot choose between brothers Step in & take care of them https://t.co/J6qFO52wGD @SusieWiles @Sarepta @douglas_ingram $SRPT @RobertKennedyJr Please help these folks out of this unbelievably horrible situation @ArkBlueCross cannot do this to this family They" [X Link](https://x.com/Angelnvestments/status/1962575663208042582) 2025-09-01T17:57Z [--] followers, [----] engagements "@ShakePryzby1 $CRWD showed who is in control 🙏" [X Link](https://x.com/Angelnvestments/status/1962579922766959011) 2025-09-01T18:14Z [--] followers, [--] engagements "$SRPT the data is alive. Breathing moving playing. Every extra step is proof that the science already won @US_FDA I challenge @fepblue to provide a transparent medically sound and logical explanation for denying my son access to #Elevidys (@Sarepta) for Duchenne Muscular Dystrophy (#DMD)the same life-changing gene therapy approved for his brother who has the same diagnosis and is covered I challenge @fepblue to provide a transparent medically sound and logical explanation for denying my son access to #Elevidys (@Sarepta) for Duchenne Muscular Dystrophy (#DMD)the same life-changing gene" [X Link](https://x.com/Angelnvestments/status/1963332692784943464) 2025-09-03T20:06Z [---] followers, [---] engagements "$SRPT countless hours of fighting.denying kids life saving therapy is a bad look. Dont make families beg for what should be automatic. @US_FDA $SRPT Just saw this on FB. BCBS reversed their decision and accepted their second son for therapy God Bless their family Good wins out https://t.co/TRlUmB9day $SRPT Just saw this on FB. BCBS reversed their decision and accepted their second son for therapy God Bless their family Good wins out https://t.co/TRlUmB9day" [X Link](https://x.com/Angelnvestments/status/1965477349069340742) 2025-09-09T18:08Z [---] followers, [---] engagements "$SRPT Weekly #Exondys51 kept him in the fight. That was gen-1 tech. Now we got Elevidys one and done built to flip the script on DMD. He will be [--] years old in January and still thriving with help from his weekly #Exondys51 treatment. 💪🏼💪🏼💪🏼 #Grateful ❤ #DUCHENNE https://t.co/jEh9J36xbs He will be [--] years old in January and still thriving with help from his weekly #Exondys51 treatment. 💪🏼💪🏼💪🏼 #Grateful ❤ #DUCHENNE https://t.co/jEh9J36xbs" [X Link](https://x.com/Angelnvestments/status/1969089465315434993) 2025-09-19T17:21Z [--] followers, [---] engagements "$SRPT @adamfeuerstein This [--] yr old boy with Duchenne is preparing to plead his case to NYC Medicaid about why access to Elevidys matters. Imagine needing to explain to adults why your life is worth the cost it is ridiculous @Sarepta @US_FDA $SRPT https://t.co/JtEZG94Cq9 @adamfeuerstein This [--] yr old boy with Duchenne is preparing to plead his case to NYC Medicaid about why access to Elevidys matters. Imagine needing to explain to adults why your life is worth the cost it is ridiculous @Sarepta @US_FDA $SRPT https://t.co/JtEZG94Cq9" [X Link](https://x.com/Angelnvestments/status/1977060547087786360) 2025-10-11T17:15Z [---] followers, [---] engagements "$SRPT didnt compare random kids they used matched external controls meaning same age same baseline function same disease severity. When Elevidys kids hold [----] and the others drop [----] that gap was never and will never be luck" [X Link](https://x.com/Angelnvestments/status/1977821921216753767) 2025-10-13T19:41Z [---] followers, 10.9K engagements "$SRPT Three years is an eternity in DMD. Without treatment DMD kids usually lose walking ability between ages [---]. Holding stable for [--] years in that window is like turning back the disease clock Elevidys is slowing decline & bending the disease curve. $SRPT didnt compare random kids they used matched external controls meaning same age same baseline function same disease severity. When Elevidys kids hold [----] and the others drop [----] that gap was never and will never be luck https://t.co/DGxc0PBm1B $SRPT didnt compare random kids they used matched external controls meaning same age same" [X Link](https://x.com/Angelnvestments/status/1977822556490256762) 2025-10-13T19:43Z [---] followers, [----] engagements "$Srpt NY Medicaid denying Elevidys is beyond messed up. Weve got families watching their kids lose muscle every week and some committee thinks they know better than FDA Bias politics and red tape have no place in rare disease care. Let parents make the call. $SRPT This member of the @NYSDOHMEDICAID Drug Utilization Review Board just votedthen gloatedto deny coverage of FDA-approved #Elevidys for children in New York living with #duchenne. Last year she retweeted this hit piece. Bias much $SRPT This member of the @NYSDOHMEDICAID Drug Utilization Review Board just votedthen gloatedto deny" [X Link](https://x.com/Angelnvestments/status/1981093349273784769) 2025-10-22T20:20Z [---] followers, [---] engagements "$SRPT And again you dont hold a 3-point gap in NSAA for [--] years by luck. Thats real functional preservation the kind DMD families pray for daily. Elevidys works. Full stop. $SRPT didnt compare random kids they used matched external controls meaning same age same baseline function same disease severity. When Elevidys kids hold [----] and the others drop [----] that gap was never and will never be luck https://t.co/DGxc0PBm1B $SRPT didnt compare random kids they used matched external controls meaning same age same baseline function same disease severity. When Elevidys kids hold [----] and the others" [X Link](https://x.com/Angelnvestments/status/1981096026842026490) 2025-10-22T20:31Z [---] followers, [----] engagements "$SRPT people are literally dying waiting on approvals and these clowns are playing HR musical chairs. What the actual hell is happening at the FDA Cant decide whats worse the leadership chaos or the fact nobody there seems embarrassed about it anymore. An eye-catching -- and curious -- detail from @LizzyLaw_'s FDA story: Nicole Verdun the official who was marched out of the FDA earlier this year "may be returning from administrative leave after an investigation apparently found that her behavior did not merit permanent An eye-catching -- and curious -- detail from @LizzyLaw_'s FDA story:" [X Link](https://x.com/Angelnvestments/status/1984750548562964880) 2025-11-01T22:33Z [---] followers, [----] engagements "$SRPT The issue isnt which functional test you pick. 4-step 6MWT NSAA they all measure short-term movement not long-term muscle preservation. Duchenne progression takes years. A 2-year functional test will always understate biological impact. $SRPT changed the primary endpoint of the ESSENCE study bc they believed the new endpoint was more sensitive -- and it still failed. $SRPT changed the primary endpoint of the ESSENCE study bc they believed the new endpoint was more sensitive -- and it still failed" [X Link](https://x.com/Angelnvestments/status/1986129394864206144) 2025-11-05T17:52Z [---] followers, [---] engagements "$SRPT I think they should call it Vinay and Prasad Administration. Jesus its a circus in there. Scientists walking out leadership feuding. People might actually get the treatments they need before they die if the agency stopped acting like a damn soap opera. @Angelnvestments It is Prasad Literally the worst thing ever happened at FDA @Angelnvestments It is Prasad Literally the worst thing ever happened at FDA" [X Link](https://x.com/Angelnvestments/status/1988332842372456595) 2025-11-11T19:47Z [---] followers, [----] engagements "$CLOV Could get a dead cat bounce or whatever that creature is. $CLOV Not a bad time to reload the boat https://t.co/AHLjb7N9GY $CLOV Not a bad time to reload the boat https://t.co/AHLjb7N9GY" [X Link](https://x.com/Angelnvestments/status/1991912446764937538) 2025-11-21T16:51Z [---] followers, [----] engagements "$SRPT $SRPT Boxed warning or not Elevidys is still the only therapy actually changing the trajectory of DMD thats the part nobody can replace. Data keeps building they still own the field. Strip out the drama and the long term story is still stupid strong. https://t.co/32acZO8NNf $SRPT Boxed warning or not Elevidys is still the only therapy actually changing the trajectory of DMD thats the part nobody can replace. Data keeps building they still own the field. Strip out the drama and the long term story is still stupid strong. https://t.co/32acZO8NNf" [X Link](https://x.com/Angelnvestments/status/1991912640109776939) 2025-11-21T16:52Z [---] followers, [---] engagements "Disagree. Many decisions being criticized were made with FDA alignment/patient demand/incomplete long-term data basically the reality of rare disease drug development. $SRPT repeatedly worked within regulatory frameworks allowing accelerated approval based on surrogate endpoints The Worst Biopharma CEO of [----] made decisions with tragic consequences Doug Ingram Sarepta Therapeutics. $SRPT Is anyone surprised Does anyone disagree https://t.co/1I7VrJFzpC The Worst Biopharma CEO of [----] made decisions with tragic consequences Doug Ingram Sarepta Therapeutics. $SRPT Is anyone surprised Does" [X Link](https://x.com/Angelnvestments/status/2001350832193933436) 2025-12-17T17:56Z [---] followers, [---] engagements "$CLOV I should have bought more I ONLY INVEST IN THE BEST $CLOV https://t.co/Wg2NoKrssX I ONLY INVEST IN THE BEST $CLOV https://t.co/Wg2NoKrssX" [X Link](https://x.com/Angelnvestments/status/2001355918039207955) 2025-12-17T18:16Z [---] followers, [---] engagements "$SRPT It's always easy to react to the cost. Harder to appreciate how rare it is for a company to actually deliver something like this. People dont see how much had to fail before one thing finally worked. How could a treatment for a form of muscular dystrophy have a $3.2 million price tag The CEO who manufactures the drug explains. https://t.co/RweTMHIw1n https://t.co/4oIRHt3r1o How could a treatment for a form of muscular dystrophy have a $3.2 million price tag The CEO who manufactures the drug explains. https://t.co/RweTMHIw1n https://t.co/4oIRHt3r1o" [X Link](https://x.com/Angelnvestments/status/2008927978902724939) 2026-01-07T15:45Z [---] followers, [---] engagements "$SRPT For families who had nothing but supportive care for years this wasnt some abstract debate about risk profiles. It was the first sign that nothing might not be the only answer forever. Imperfect progress is still progress even if it makes people uncomfortable @Angelnvestments I also don't understand the criticism of Elevidys. Yes SRPT didn't do some things well last year and yes Elevidys has problematic side effects. But it is currently the only treatment for a virtually always fatal and malignant disease. We should be glad that someone is @Angelnvestments I also don't understand the" [X Link](https://x.com/Angelnvestments/status/2008961763677757916) 2026-01-07T17:59Z [---] followers, [---] engagements "I do really care about how many kids get access to ELEVIDYS sooner rather than later. Every month they have to wait is something lost forever. If the market starts paying attention to $SRPT again hopefully that brings real pressure to expand access" [X Link](https://x.com/Angelnvestments/status/2014347309169913959) 2026-01-22T14:39Z [---] followers, [---] engagements "#Bitfarms to buy Stronghold Digital Mining for $164M $SDIG https://www.msn.com/en-us/money/markets/bitfarms-to-buy-stronghold-digital-mining-for-164m/ar-AA1pb7Msocid=finance-verthp-feeds&apiversion=v2&noservercache=1&domshim=1&renderwebcomponents=1&wcseo=1&batchservertelemetry=1&noservertelemetry=1 https://www.msn.com/en-us/money/markets/bitfarms-to-buy-stronghold-digital-mining-for-164m/ar-AA1pb7Msocid=finance-verthp-feeds&apiversion=v2&noservercache=1&domshim=1&renderwebcomponents=1&wcseo=1&batchservertelemetry=1&noservertelemetry=1" [X Link](https://x.com/Angelnvestments/status/1884573417111715951) 2025-01-29T12:04Z [---] followers, [--] engagements "Read this piece on $LMR working on a graphite supply chain in Canada interesting to see a smaller name moving into the EV materials space. Makes me wonder if domestic graphite projects like this could actually reduce dependence on China long term. https://stockhouse.com/news/newswire/2025/10/20/lomiko-metals-building-canada-s-graphite-supply-chain https://stockhouse.com/news/newswire/2025/10/20/lomiko-metals-building-canada-s-graphite-supply-chain" [X Link](https://x.com/Angelnvestments/status/1981007810298290624) 2025-10-22T14:40Z [---] followers, [--] engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
@Angelnvestments Angel Investments
Angel Investments posts on X about $srpt, $tsla, $clov, tsla the most. They currently have [---] followers and [--] posts still getting attention that total [--] engagements in the last [--] hours.
Engagements: [--] #
- [--] Week [-----] +8,338%
- [--] Month [-----] +5.40%
- [--] Months [------] +30,770%
- [--] Year [------] +2,383%
Mentions: [--] #
- [--] Week [--] +100%
- [--] Month [--] +75%
- [--] Months [--] +3,200%
- [--] Year [--] +183%
Followers: [---] #
- [--] Month [---] +1.80%
- [--] Months [---] +34%
- [--] Year [---] +39%
CreatorRank: [---------] #
Social Influence
Social category influence stocks 79.59% technology brands 12.24% finance 10.2% cryptocurrencies 8.16% automotive brands 6.12% countries 4.08% us election 2.04%
Social topic influence $srpt 53.06%, $tsla 10.2%, $clov 10.2%, tsla 8.16%, bitcoin 6.12%, strong 4.08%, tesla 4.08%, $amzn 4.08%, $crwd 4.08%, ceo 4.08%
Top accounts mentioned or mentioned by @usfda @stockmktnewz @sarepta @adamfeuerstein @jimcramers @jimcramer @wgaeast @theafm @directorsguild @iatse @teamsters @teamsters399 @sagaftra @optionsheisman @emerginvestor @bironclark @drmakaryfda @susiewiles @douglasingram @robertkennedyjr
Top assets mentioned Sarepta Therapeutics, Inc. (SRPT) Tesla, Inc. (TSLA) Bitcoin (BTC) Amazon.com, Inc. (AMZN) Crowdstrike Holdings Inc (CRWD) Freeport-McMoRan Inc (FCX) Bill.com Holdings, Inc. (BILL) Riskified Ltd. (RSKD) MARA Holdings, Inc. (MARA) CATHEDRA BITCOIN SUB VTG (CBTTF) Hut [--] Mining Corp. (HUT) Apple, Inc. (AAPL) NVIDIA Corp. (NVDA) Gains (GAINS) Stronghold Digital Mining, Inc. (SDIG) Bitfarms Ltd. (BITF) Lumerin (LMR)
Top Social Posts
Top posts by engagements in the last [--] hours
"$SRPT mixing unrelated bad news into this and Adam can spin any conclusion. If the data were weak it wouldnt need population mixing to attack it. Ambulatory outcomes should be judged on ambulatory data. $SRPT 📷 So misleading by @adamfeuerstein: In this morning's press release this is all that $SRPT discloses about Elevidys safety one year after liver toxicity liver-injury related hospitalizations and deaths due to acute liver failure nearly ended the gene therapy. $SRPT 📷 So misleading by @adamfeuerstein: In this morning's press release this is all that $SRPT discloses about Elevidys safety"
X Link 2026-01-27T16:32Z [---] followers, [---] engagements
"The drug is ready to be tested in people. For brain drugs getting to this point is already a big hurdle. This is where $SRPT starts answering the most important question: can the drug reach the right place and be safe And for Huntingtons that alone makes it worth watching. $SRPT Announces Approval of Clinical Trial Application for SRP-1005 Its Investigational Treatment for Huntingtons Disease The first-in-human clinical study of SRP-1005 known as INSIGHTT is expected to begin in Q2. $SRPT Announces Approval of Clinical Trial Application for SRP-1005 Its Investigational Treatment for"
X Link 2026-02-08T11:04Z [---] followers, [---] engagements
"$FCX has been holding its gains well after a strong run. Pullbacks look more like digestion than distribution which usually argues for continuation rather than a top"
X Link 2026-02-11T05:18Z [---] followers, [--] engagements
"What stands out here is platform optionality. CNS delivery has been the bottleneck for RNA therapies in neurodegeneration. Phase [--] is about proving the platform belongs in the brain. Safety and delivery come first everything else builds from there. This is a solid start. $SRPT 📢 : New Zealand Approves $SRPT Sareptas First-in-Human Trial for Huntingtons Drug 👉 : ➤ New Zealand regulator approves Sareptas - clinical trial application. ➤ Phase study to begin in 📢 : New Zealand Approves $SRPT Sareptas First-in-Human Trial for Huntingtons Drug 👉 : ➤ New Zealand regulator approves Sareptas -"
X Link 2026-02-11T18:51Z [---] followers, [---] engagements
"Top ETFs: $DWCR $QQQ"
X Link 2021-08-19T12:40Z [--] followers, [--] engagements
"Top Stock Gainers: $BILL $NEGG $CIIHF $ADGI $RSKD #stockstowatch #StockMarket"
X Link 2021-08-29T18:52Z [--] followers, [--] engagements
"Cathedral Bitcoin $CBIT.V $CBTTF is sneaking above the [--] and [---] dma coiling on the launch pad 🚀📈 Crypto stocks like $HUT $MARA $INTV starting to rev up with major volume. Volume often precedes price. Exciting times in the world of #Bitcoin and #cryptocurrency #CryptoStocks Cathedral Bitcoin $CBIT.V $CBTTF Price sneaking above [--] and [---] dma. Coiling on launch pad. Crypto stocks starting to rev. Major volume yesterday. Volume tends to precede price. $HUT $MARA $BTCUSD $INTV https://t.co/lcEaDWwFIW Cathedral Bitcoin $CBIT.V $CBTTF Price sneaking above [--] and [---] dma. Coiling on launch pad."
X Link 2023-04-14T00:00Z [--] followers, [---] engagements
"NEWS: @jimcramer's Lightning Round: Trane Technologies is a buy.🧐🙌 Its that time again #MadMoney host @jimcramer rings the lightning round bell which means hes giving his answers to callers stock questions at rapid speed. #Bitcoin #stockmarket $BTCL"
X Link 2024-07-24T12:25Z [--] followers, [--] engagements
"@WGAEast @The_AFM @directorsguild @IATSE @Teamsters @Teamsters_399 @sagaftra Unions and video game studios don't have the best relationship. Not many games will use unionized labor when equally talented VA are available or now AI can do it for much less. Union workers might lose their job opportunities"
X Link 2024-07-31T11:45Z [--] followers, [--] engagements
"Analyst Predicts 'Explosive' $BTC Growth to $150K as Four-Year Cycle Advances. Check it out here👇 https://finance.yahoo.com/news/analyst-predicts-explosive-bitcoin-growth-085839736.html https://finance.yahoo.com/news/analyst-predicts-explosive-bitcoin-growth-085839736.html"
X Link 2024-10-09T10:55Z [--] followers, [--] engagements
"MacBook Pro Release Date Latest: Apples Ambitious Plans $AAPL #apple https://www.forbes.com/sites/ewanspence/2024/10/27/macbook-pro-release-date-latest-apples-ambitious-plans/ https://www.forbes.com/sites/ewanspence/2024/10/27/macbook-pro-release-date-latest-apples-ambitious-plans/"
X Link 2024-10-28T06:13Z [--] followers, [--] engagements
"@StockMKTNewz technology is gold: 1) $TSLA 2) $NNDM 3) $CLOV"
X Link 2024-10-28T06:20Z [--] followers, [---] engagements
"Tesla shares lost nearly 7% over the last two trading sessions closing Friday at $431.66. $TSLA #DonaldTrump https://www.investopedia.com/watch-these-tesla-price-levels-as-stock-hits-brakes-ahead-of-q4-deliveries-report-8767370 https://www.investopedia.com/watch-these-tesla-price-levels-as-stock-hits-brakes-ahead-of-q4-deliveries-report-8767370"
X Link 2024-12-30T10:00Z [--] followers, [--] engagements
"Is Tesla Stock a Buy in [----] $TSLA #StocksToBuy https://www.fool.com/investing/2024/12/31/is-tesla-stock-a-buy-in-2025/ https://www.fool.com/investing/2024/12/31/is-tesla-stock-a-buy-in-2025/"
X Link 2025-01-02T17:24Z [--] followers, [--] engagements
"@StockMKTNewz go buy $TSLA"
X Link 2025-01-07T09:47Z [--] followers, [---] engagements
"@OptionsHeisman @StockMKTNewz do you think companies like $AAPL and $MSFT can re-enter this level of innovation or have $NVDA and $TSLA permanently shifted the balance of power"
X Link 2025-01-07T09:55Z [--] followers, [---] engagements
"reclaimed its [------] buy point during recent gains $AMZN https://www.investors.com/research/magnificent-seven-stocks-january-2025/ http://Amazon.com https://www.investors.com/research/magnificent-seven-stocks-january-2025/ http://Amazon.com"
X Link 2025-01-14T16:59Z [--] followers, [--] engagements
"@EmergInvestor Hard to bet against $AMZN. AWS alone makes them a contender.and any improvements in consumer confidence would push them further ahead"
X Link 2025-01-21T17:02Z [--] followers, [--] engagements
"@BironClark Long term plays take long term energy. adding slowly keeping an eye on $SRPT too"
X Link 2025-07-04T17:09Z [--] followers, [--] engagements
"$SRPT doing $1.4B without non-ambulatory. Markets only pricing in risk. Not potential. If the sirolimus combo works in non ambulatory patientsTheres no ceiling on Elevidys anymore. Half the DMD market unlock Dr. Barry explains that liver toxicity in non amb patients can be addressed with sirolimus. $srpt is using far less than transplant level dosing just enough to calm the immune system shield the liver and avoid the collateral damage that comes with heavier dosing- safer. Dr. Barry explains that liver toxicity in non amb patients can be addressed with sirolimus. $srpt is using far less than"
X Link 2025-08-19T20:11Z [--] followers, [----] engagements
"$SRPT a diagnosis of Duchenne is almost a predetermined fate. Median life expectancy for Duchenne is just [--] years. So if a therapy gives even 3-5 more years of walking breathing living then its everything. And thats exactly what makes Elevidys so important. $SRPT 74% dead before [--] in DMD. If you call that safer than Elevidys youre gaslighting reality. Safety isnt dying on schedule $SRPT 74% dead before [--] in DMD. If you call that safer than Elevidys youre gaslighting reality. Safety isnt dying on schedule"
X Link 2025-08-25T18:17Z [--] followers, [----] engagements
"$SRPT Mr Adam says that like science isnt allowed to evolve. over a thousand kids got a shot at walking longer breathing better and zero death. If your biggest concern is the name of the endpoint not the outcome maybe youve forgotten who the real patient is Adam. Idk. Lot of criticism of $SRPT is fair. But hard to really say that a drug which is in such robust demand from the physician community is all smoke and mirrors. Its certainly not a perfect drug. But its also pretty clearly not inert from an efficacy perspective. Idk. Lot of criticism of $SRPT is fair. But hard to really say that a"
X Link 2025-08-25T18:25Z [--] followers, [----] engagements
"$SRPT Accelerated Approval was created for therapies that show surrogate benefit in serious conditions with no cures. Elevidys was the exact use case Congress envisioned. Anyone calling it controversial just simply doesnt understand the law"
X Link 2025-08-26T17:11Z [--] followers, [---] engagements
"$crwd eyes on [------] as the real trigger $CRWD beauty beauty beauty. Hope everyone caught this. https://t.co/vBrk4CPF7j $CRWD beauty beauty beauty. Hope everyone caught this. https://t.co/vBrk4CPF7j"
X Link 2025-08-29T17:17Z [--] followers, [---] engagements
"$CLOV New corp filings. New hires. New customers"
X Link 2025-08-29T17:22Z [--] followers, [---] engagements
"$SRPT We all know how quickly health can fade. Elevidys had offered a chance people should have the right to take it before the moment slips away. Childhood is short fragile and precious. No family should watch those steps disappear while answers sit waiting"
X Link 2025-09-01T17:44Z [--] followers, [----] engagements
"Every day we wait more families live this nightmare. Regulators and insurers please dont make parents choose which child survives $SRPT @DrMakaryFDA @US_FDA @SusieWiles @Sarepta @douglas_ingram $SRPT @RobertKennedyJr Please help these folks out of this unbelievably horrible situation @ArkBlueCross cannot do this to this family They cannot choose between brothers Step in & take care of them https://t.co/J6qFO52wGD @SusieWiles @Sarepta @douglas_ingram $SRPT @RobertKennedyJr Please help these folks out of this unbelievably horrible situation @ArkBlueCross cannot do this to this family They"
X Link 2025-09-01T17:57Z [--] followers, [----] engagements
"@ShakePryzby1 $CRWD showed who is in control 🙏"
X Link 2025-09-01T18:14Z [--] followers, [--] engagements
"$SRPT the data is alive. Breathing moving playing. Every extra step is proof that the science already won @US_FDA I challenge @fepblue to provide a transparent medically sound and logical explanation for denying my son access to #Elevidys (@Sarepta) for Duchenne Muscular Dystrophy (#DMD)the same life-changing gene therapy approved for his brother who has the same diagnosis and is covered I challenge @fepblue to provide a transparent medically sound and logical explanation for denying my son access to #Elevidys (@Sarepta) for Duchenne Muscular Dystrophy (#DMD)the same life-changing gene"
X Link 2025-09-03T20:06Z [---] followers, [---] engagements
"$SRPT countless hours of fighting.denying kids life saving therapy is a bad look. Dont make families beg for what should be automatic. @US_FDA $SRPT Just saw this on FB. BCBS reversed their decision and accepted their second son for therapy God Bless their family Good wins out https://t.co/TRlUmB9day $SRPT Just saw this on FB. BCBS reversed their decision and accepted their second son for therapy God Bless their family Good wins out https://t.co/TRlUmB9day"
X Link 2025-09-09T18:08Z [---] followers, [---] engagements
"$SRPT Weekly #Exondys51 kept him in the fight. That was gen-1 tech. Now we got Elevidys one and done built to flip the script on DMD. He will be [--] years old in January and still thriving with help from his weekly #Exondys51 treatment. 💪🏼💪🏼💪🏼 #Grateful ❤ #DUCHENNE https://t.co/jEh9J36xbs He will be [--] years old in January and still thriving with help from his weekly #Exondys51 treatment. 💪🏼💪🏼💪🏼 #Grateful ❤ #DUCHENNE https://t.co/jEh9J36xbs"
X Link 2025-09-19T17:21Z [--] followers, [---] engagements
"$SRPT @adamfeuerstein This [--] yr old boy with Duchenne is preparing to plead his case to NYC Medicaid about why access to Elevidys matters. Imagine needing to explain to adults why your life is worth the cost it is ridiculous @Sarepta @US_FDA $SRPT https://t.co/JtEZG94Cq9 @adamfeuerstein This [--] yr old boy with Duchenne is preparing to plead his case to NYC Medicaid about why access to Elevidys matters. Imagine needing to explain to adults why your life is worth the cost it is ridiculous @Sarepta @US_FDA $SRPT https://t.co/JtEZG94Cq9"
X Link 2025-10-11T17:15Z [---] followers, [---] engagements
"$SRPT didnt compare random kids they used matched external controls meaning same age same baseline function same disease severity. When Elevidys kids hold [----] and the others drop [----] that gap was never and will never be luck"
X Link 2025-10-13T19:41Z [---] followers, 10.9K engagements
"$SRPT Three years is an eternity in DMD. Without treatment DMD kids usually lose walking ability between ages [---]. Holding stable for [--] years in that window is like turning back the disease clock Elevidys is slowing decline & bending the disease curve. $SRPT didnt compare random kids they used matched external controls meaning same age same baseline function same disease severity. When Elevidys kids hold [----] and the others drop [----] that gap was never and will never be luck https://t.co/DGxc0PBm1B $SRPT didnt compare random kids they used matched external controls meaning same age same"
X Link 2025-10-13T19:43Z [---] followers, [----] engagements
"$Srpt NY Medicaid denying Elevidys is beyond messed up. Weve got families watching their kids lose muscle every week and some committee thinks they know better than FDA Bias politics and red tape have no place in rare disease care. Let parents make the call. $SRPT This member of the @NYSDOHMEDICAID Drug Utilization Review Board just votedthen gloatedto deny coverage of FDA-approved #Elevidys for children in New York living with #duchenne. Last year she retweeted this hit piece. Bias much $SRPT This member of the @NYSDOHMEDICAID Drug Utilization Review Board just votedthen gloatedto deny"
X Link 2025-10-22T20:20Z [---] followers, [---] engagements
"$SRPT And again you dont hold a 3-point gap in NSAA for [--] years by luck. Thats real functional preservation the kind DMD families pray for daily. Elevidys works. Full stop. $SRPT didnt compare random kids they used matched external controls meaning same age same baseline function same disease severity. When Elevidys kids hold [----] and the others drop [----] that gap was never and will never be luck https://t.co/DGxc0PBm1B $SRPT didnt compare random kids they used matched external controls meaning same age same baseline function same disease severity. When Elevidys kids hold [----] and the others"
X Link 2025-10-22T20:31Z [---] followers, [----] engagements
"$SRPT people are literally dying waiting on approvals and these clowns are playing HR musical chairs. What the actual hell is happening at the FDA Cant decide whats worse the leadership chaos or the fact nobody there seems embarrassed about it anymore. An eye-catching -- and curious -- detail from @LizzyLaw_'s FDA story: Nicole Verdun the official who was marched out of the FDA earlier this year "may be returning from administrative leave after an investigation apparently found that her behavior did not merit permanent An eye-catching -- and curious -- detail from @LizzyLaw_'s FDA story:"
X Link 2025-11-01T22:33Z [---] followers, [----] engagements
"$SRPT The issue isnt which functional test you pick. 4-step 6MWT NSAA they all measure short-term movement not long-term muscle preservation. Duchenne progression takes years. A 2-year functional test will always understate biological impact. $SRPT changed the primary endpoint of the ESSENCE study bc they believed the new endpoint was more sensitive -- and it still failed. $SRPT changed the primary endpoint of the ESSENCE study bc they believed the new endpoint was more sensitive -- and it still failed"
X Link 2025-11-05T17:52Z [---] followers, [---] engagements
"$SRPT I think they should call it Vinay and Prasad Administration. Jesus its a circus in there. Scientists walking out leadership feuding. People might actually get the treatments they need before they die if the agency stopped acting like a damn soap opera. @Angelnvestments It is Prasad Literally the worst thing ever happened at FDA @Angelnvestments It is Prasad Literally the worst thing ever happened at FDA"
X Link 2025-11-11T19:47Z [---] followers, [----] engagements
"$CLOV Could get a dead cat bounce or whatever that creature is. $CLOV Not a bad time to reload the boat https://t.co/AHLjb7N9GY $CLOV Not a bad time to reload the boat https://t.co/AHLjb7N9GY"
X Link 2025-11-21T16:51Z [---] followers, [----] engagements
"$SRPT $SRPT Boxed warning or not Elevidys is still the only therapy actually changing the trajectory of DMD thats the part nobody can replace. Data keeps building they still own the field. Strip out the drama and the long term story is still stupid strong. https://t.co/32acZO8NNf $SRPT Boxed warning or not Elevidys is still the only therapy actually changing the trajectory of DMD thats the part nobody can replace. Data keeps building they still own the field. Strip out the drama and the long term story is still stupid strong. https://t.co/32acZO8NNf"
X Link 2025-11-21T16:52Z [---] followers, [---] engagements
"Disagree. Many decisions being criticized were made with FDA alignment/patient demand/incomplete long-term data basically the reality of rare disease drug development. $SRPT repeatedly worked within regulatory frameworks allowing accelerated approval based on surrogate endpoints The Worst Biopharma CEO of [----] made decisions with tragic consequences Doug Ingram Sarepta Therapeutics. $SRPT Is anyone surprised Does anyone disagree https://t.co/1I7VrJFzpC The Worst Biopharma CEO of [----] made decisions with tragic consequences Doug Ingram Sarepta Therapeutics. $SRPT Is anyone surprised Does"
X Link 2025-12-17T17:56Z [---] followers, [---] engagements
"$CLOV I should have bought more I ONLY INVEST IN THE BEST $CLOV https://t.co/Wg2NoKrssX I ONLY INVEST IN THE BEST $CLOV https://t.co/Wg2NoKrssX"
X Link 2025-12-17T18:16Z [---] followers, [---] engagements
"$SRPT It's always easy to react to the cost. Harder to appreciate how rare it is for a company to actually deliver something like this. People dont see how much had to fail before one thing finally worked. How could a treatment for a form of muscular dystrophy have a $3.2 million price tag The CEO who manufactures the drug explains. https://t.co/RweTMHIw1n https://t.co/4oIRHt3r1o How could a treatment for a form of muscular dystrophy have a $3.2 million price tag The CEO who manufactures the drug explains. https://t.co/RweTMHIw1n https://t.co/4oIRHt3r1o"
X Link 2026-01-07T15:45Z [---] followers, [---] engagements
"$SRPT For families who had nothing but supportive care for years this wasnt some abstract debate about risk profiles. It was the first sign that nothing might not be the only answer forever. Imperfect progress is still progress even if it makes people uncomfortable @Angelnvestments I also don't understand the criticism of Elevidys. Yes SRPT didn't do some things well last year and yes Elevidys has problematic side effects. But it is currently the only treatment for a virtually always fatal and malignant disease. We should be glad that someone is @Angelnvestments I also don't understand the"
X Link 2026-01-07T17:59Z [---] followers, [---] engagements
"I do really care about how many kids get access to ELEVIDYS sooner rather than later. Every month they have to wait is something lost forever. If the market starts paying attention to $SRPT again hopefully that brings real pressure to expand access"
X Link 2026-01-22T14:39Z [---] followers, [---] engagements
"#Bitfarms to buy Stronghold Digital Mining for $164M $SDIG https://www.msn.com/en-us/money/markets/bitfarms-to-buy-stronghold-digital-mining-for-164m/ar-AA1pb7Msocid=finance-verthp-feeds&apiversion=v2&noservercache=1&domshim=1&renderwebcomponents=1&wcseo=1&batchservertelemetry=1&noservertelemetry=1 https://www.msn.com/en-us/money/markets/bitfarms-to-buy-stronghold-digital-mining-for-164m/ar-AA1pb7Msocid=finance-verthp-feeds&apiversion=v2&noservercache=1&domshim=1&renderwebcomponents=1&wcseo=1&batchservertelemetry=1&noservertelemetry=1"
X Link 2025-01-29T12:04Z [---] followers, [--] engagements
"Read this piece on $LMR working on a graphite supply chain in Canada interesting to see a smaller name moving into the EV materials space. Makes me wonder if domestic graphite projects like this could actually reduce dependence on China long term. https://stockhouse.com/news/newswire/2025/10/20/lomiko-metals-building-canada-s-graphite-supply-chain https://stockhouse.com/news/newswire/2025/10/20/lomiko-metals-building-canada-s-graphite-supply-chain"
X Link 2025-10-22T14:40Z [---] followers, [--] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing